3rd Quarter - Report

MEHLMAN CONSULTING, INC. for VIZIENT INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Healthcare coverage; prescription drug costs; group purchasing issues; drug shortage issues. 340B Drug Pricing Program. S. 1895, No Surprises Act. S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136 H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act - Public Law No: 116-123 H.R. 6201, the Families First Coronavirus Response Act - Public Law No: 116-127 CARES Act Implementation and H.R. 266, Paycheck Protection Program and Health Care Enhancement Act and H.R. 6800, HEROES Acts S. 178, HEALS Act

LobbyistCovered position, as disclosed
LAUREN ARONSON —
DEAN ROSEN —

Contacted: Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS)

Bills named: S. 1895 (116th), S. 178 (116th), H.R. 3 (116th), H.R. 266 (116th), H.R. 6201 (116th), H.R. 6800 (116th), H.R. 748 (116th), H.R. 6074 (116th), S. 2543 (116th)

Medicare/Medicaid MMM

Healthcare transparency, costs and access to affordable medication and other healthcare items and services. S. 178, HEALS Act.

LobbyistCovered position, as disclosed
DEAN ROSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Office of the Vice President of the United States; White House Office; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 178 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.